Tricida, Inc. Banner Image

Tricida, Inc.

  • Ticker TCDA
    Exchange NASDAQ More
  • Industry Drug Manufacturers - Major More
  • Sector Healthcare More
Tricida, Inc. Logo Image
  • 51-200 Employees
  • Based in South San Francisco, California
Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD. Tricida is currently conducting the VALOR-CKD clinical trial to evaluate the efficacy and safety of veverimer in delaying CKD progressionMore in subjects with metabolic acidosis. There are no FDA-approved treatments for chronic metabolic acidosis.
4.8 / 5.0 (213)

Tricida, Inc. reports have an aggregate usefulness score of 4.8 based on 213 reviews.

Tricida, Inc.

Most Recent Annual Report

Tricida, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports

Tricida, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!